Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Form 8 (OPD) - Gresham Technologies Plc

15 Apr 2024 17:32

RNS Number : 6969K
Gresham Technologies PLC
15 April 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

GRESHAM TECHNOLOGIES PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GRESHAM TECHNOLOGIES PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

15/4/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a) Ordinary shares of ÂŁ0.05 each in the capital of Gresham Technologies plc ("Ordinary Shares") held by the directors of Gresham Technologies plc, their close relatives and related trusts (excluding options which are set out in (b) below:

Director

Number of Ordinary Shares

Percentage of issued share capital

Ian Manocha

166,640

0.20

Thomas Mullan

76,054

0.09

Andrew Balchin

17,608

0.02

Jennifer Knott

31,250

0.04

Oliver Scott

155,434

0.19

 

(b) Options and awards held by the directors of Gresham Technologies plc, their close relatives and related trusts:

Director

Number of Ordinary Shares under option

Vesting details

Exercise Price

Ian Manocha

1,500,000

Granted on 1 June 2015

Vested on 31 May 2018

Expires on 29 May 2025

ÂŁ1.11

104,008

Granted on 18 March 2020

Vested on 18 March 2023

Expires on 18 March 2030

Nil

Up to 174,944

Granted on 31 March 2022

Vesting on 31 March 2025

Expires on 31 March 2032

Nil

Up to 135,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 68,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 197,185

Granted on 31 March 2023

Vesting on 31 March 2026

Expires on 31 March 2033

Nil

Thomas Mullan

200,000

Granted on 14 March 2018

Vested on 13 March 2021

Expires on 11 March 2028

ÂŁ2.27

100,000

Granted on 28 March 2019

Vested on 27 March 2022

Expires on 25 March 2029

ÂŁ0.97

67,532

Granted on 18 March 2020

Vested on 18 March 2023

Expires on 18 March 2030

Nil

Up to 107,736

Granted on 31 March 2022

Vesting on 31 March 2025

Expires on 31 March 2032

Nil

Up to 75,000

Granted on 21 October 2021

Vesting on 20 October 2024

Expires on 19 October 2031

Nil

Up to 118,919

Granted on 31 March 2023

Vesting on 31 March 2026

Expires on 31 March 2033

Nil

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

15/4/2024

Contact name:

Jonathan Cathie

Telephone number:

+44 (0) 207 653 0290

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAKLSFDFLEFA
Date   Source Headline
28th Aug 20097:00 amRNSInterim Results
29th Jun 20099:51 amRNSResult of AGM
3rd Jun 20092:58 pmRNSHolding(s) in Company
18th May 20091:30 pmRNSAnnual Information Update
18th May 20091:20 pmRNSNotice of AGM and Annual Report
11th May 20097:00 amRNSProduct Launch
29th Apr 20097:00 amRNSAppointment of Sales Director
22nd Apr 20097:01 amRNSInterim Management Statement
22nd Apr 20097:00 amRNSAnnual Financial Report Announcement
9th Apr 20094:04 pmRNSSale and Leaseback of Freehold Property
1st Apr 20097:00 amRNSMajor New Contract
16th Mar 20092:25 pmRNSHolding(s) in Company
3rd Mar 20092:28 pmRNSHolding(s) in Company
6th Feb 20093:33 pmRNSHolding(s) in Company
19th Jan 200911:49 amRNSHolding(s) in Company
15th Jan 20099:57 amRNSHolding(s) in Company
14th Jan 20093:48 pmRNSDirector/PDMR Shareholding
13th Jan 20097:00 amRNSTrading Statement
19th Nov 200812:07 pmRNSInterim Management Statement
28th Oct 20083:02 pmRNSDirector/PDMR Shareholding
19th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSRe Alliance
3rd Sep 20089:02 amRNSDisposal
26th Aug 20087:00 amRNSInterim Results
17th Jul 200810:43 amRNSHolding(s) in Company
7th Jul 200812:52 pmRNSResult of AGM
4th Jul 20087:00 amRNSTrading Statement
5th Jun 200810:00 amRNSAGM Statement
19th May 20087:00 amRNSAnnual Information Update
6th May 20082:09 pmRNSDirector/PDMR Shareholding
30th Apr 20083:11 pmRNSDirector/PDMR Shareholding
29th Apr 20087:02 amRNSDirectorate Change
29th Apr 20087:01 amRNSInterim Management Statement
29th Apr 20087:01 amRNSFinal Results
15th Apr 20084:24 pmRNSNotice of Results
22nd Feb 20087:00 amRNSContract Award
31st Jan 20084:37 pmRNSBoard Change
21st Jan 20084:02 pmRNSDirectorate Change
8th Jan 200812:06 pmRNSDirector/PDMR Shareholding
4th Jan 20087:00 amRNSTrading Update
30th Nov 20074:00 pmRNSDirectorate Change
31st Oct 200712:54 pmRNSHolding(s) in Company
30th Oct 20073:47 pmRNSHolding(s) in Company
22nd Oct 20074:54 pmRNSDirector/PDMR Shareholding
22nd Oct 200711:16 amRNSHolding(s) in Company
28th Sep 20077:02 amRNSVoting Rights & Capital
27th Sep 20073:20 pmRNSInterest in Shares
26th Sep 20071:36 pmRNSHolding(s) in Company
25th Sep 200711:37 amRNSDirector/PDMR Shareholding
24th Sep 20077:02 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.